CD44 and neoplasm: The cell proliferation inhibition efficacy of targeted DOX-NPs exhibited a strong dose-dependent pattern, with the maximum inhibition of tumor cell proliferation found at a higher concentration of DOX in CD-44-expressed cell lines.